Clinical Research Solutions
ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of Diamond Pharma Services. Diamond Pharma Services provides regulatory affairs, pharmacovigilance, and...
Clinical Research Solutions
DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research,...
Clinical Research Solutions
Odyssey Investment Partners ("Odyssey") announced today that it has entered into an agreement to acquire ProPharma Group (or the "Company") from Linden Capital Partners. Financial terms of the...
Clinical Research Solutions
Linden Capital Partners (“Linden”), a Chicago-based private equity firm focused exclusively on the healthcare sector, announced an agreement to sell ProPharma Group (the “Company”) to Odyssey...
Clinical Research Solutions
ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Southwood Research. Based in Buckinghamshire, United Kingdom, Southwood Research is a leading provider of...
Clinical Research Solutions
ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Washington D.C.-based The Weinberg Group Inc. The Weinberg Group is a leading provider of regulatory and...
Clinical Research Solutions
ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of SOLUTIONS in Health Inc., a Canada-based provider of medical information services to the pharmaceutical,...
Clinical Research Solutions
ProPharma Group today announces the opening of a new medical information contact center in Fort Washington, Pennsylvania to accommodate our growing business. ProPharma Group, a provider of...